Company Overview
- Headquarters
- 225 2nd Ave, Waltham MA
- Website
- bioverativ.com
- Employees
- 49
- Founded in
- 2017
- Industry
- BioTech/Drugs
- Stock Symbol
- NASDAQ:BIV
Financials & Stats
Revenue
$100B
Who is Bioverativ a Sanofi company
Bioverativ, a Sanofi company, is a small biotechnology company headquartered in Waltham, Massachusetts. Employing 21 individuals, the company generates an estimated $100 million in annual revenue. Bioverativ focuses on the research, development, and commercialization of innovative therapies for individuals living with hemophilia and other rare blood disorders. Their therapies represent significant advancements in treating these conditions, marking the first major breakthroughs in over two decades. Bioverativ actively collaborates with the blood disorders community to improve the lives of those affected by these conditions. Committed to innovation, Bioverativ's therapies have been recognized as pioneering advancements in hemophilia treatment. They strive to develop solutions that address the unique challenges faced by individuals with hemophilia and other rare blood disorders. For more information about Bioverativ's research, therapies, and commitment to the blood disorders community, please visit their website at www.bioverativ.com or follow them on Twitter at @bioverativ.
Companies Similar to Bioverativ a Sanofi company
Analyze industry trends and opportunities by examining competitors and companies comparable to Bioverativ a Sanofi company, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 100M | 148 | Bedminster, NJ | 1986 | |
| 100M | 145 | Bothell, WA | 1987 | |
| 100M | Irvine, CA | |||
| 100M | 233 | Oakland, CA | ||
| 100M | 236 | South San Francisco, CA | 2011 |